Shares of Aura Biosciences, Inc. (AURA) have gained 1.8% over the past four weeks to close the last trading session at 7.52,buttherecouldstillbeasolidupsideleftinthestockifshort−termpricetargetsofWallStreetanalystsareanyindication.Goingbythepricetargets,themeanestimateof19.75 indicates a potential upside of 162.6%.The average comprises four short-term price targets ranging from a low of 19toahighof21, with a standard deviation of $0.96. While the lowest estimate ind ...